Skip to main content
. Author manuscript; available in PMC: 2011 Aug 4.
Published in final edited form as: Vaccine. 2010 Sep 17;28(45):7297–7305. doi: 10.1016/j.vaccine.2010.08.079

Fig. 4.

Fig. 4

In vivo tumor treatment experiments. C57BL/6 mice (n = 5 per group) were initially challenged with a s.c. injection of TC-1 tumor cells (2 × 105/mouse). Mice received DNA injections (100 μg of DNA/mouse) three days after tumor challenge with or without added α-GalCer (2 μg/injection). The mice were boosted 1 week later with various vaccine combination regimens, including DNA vaccine or E7-pulsed DC-1 in the presence or absence of α-GalCer. The mice vaccinated with pcDNA3 or α-GalCer was used as controls. The mice were monitored for evidence of tumor growth by twice weekly inspection and palpation. Tumor volumes were measured starting at day 7 after tumor challenge. (A) Line graph depicting tumor volumes in mice of different tumor treatments (mean ± SD values). (B) Kaplan–Meier survival analysis in mice from the tumor treatment experiments. The data shown here are from one of two representative experiments.